FDA to Consider Lifting Restrictions on Numerous Compounded Peptides Foley & Lardner Is BPC 157 Banned? Oral vs. Injectable Forms Explained What is a 503B outsourcing facility, and why are so many of them uninspected by FDA? Partnership for Safe Medicines FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of